2022 Pelvic Health Symposium
Norton Healthcare Services
Norton Children's Services
Join providers from Norton Healthcare and Bellarmine University as part of this one-day workshop designed to strengthen your awareness and understanding of pelvic health issues for women, children and men. They also will discuss growing sectors of pelvic health science, including sports medicine and gender affirming transition.
Saturday, May 21, 2022
8 a.m. to 4 p.m.
Nolen C. Allen Hall, Room 460
2120 Newburg Road
Louisville, KY 40205
Or call (502) 629-1234, option 4 to register.
Registration fee: $50 if registered by May 1, 2022. $75 by May 19, 2022.
Six student scholarships will be awarded for registration to the event. Norton Healthcare employees can apply for continuing education support through Norton Healthcare.
This event is intended for physical therapy providers, medical staff, current and future Doctor of Physical Therapy students and other interested students. Registration is required to attend this symposium.
Course objective: Inform and educate physical therapists and students about the need for pelvic health strategies to better serve our patients across the life spectrum.
Continued education units will be given to qualifying attendees.
Accreditation information: Physical therapy continuing education credits are offered through APTA and Bellarmine University.
Paul A. Adams, M.D. Emergency Medicine Matthew P. Allinder, M.D. Emergency Medicine Austin C. Baker, M.D. Emergency Medicine Jared S. Bass, D.O. Emergency Medicine Shannon M. Becht, M.D. Emergency Medicine Kristen Bublitz, D.O. Emergency Medicine […]Read Full Story
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]Read Full Story
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]Read Full Story
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]Read Full Story
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]Read Full Story